Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o
Go back to Haemonetics Reports 4th Quarter Fiscal 2016 Revenue of $243 Million, Constant Currency Revenue Growth of 10% and 7% As Reported; Fiscal 2016 Revenue of $910 Million, Constant Currency Revenue Growth o| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.84 -0.08 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.92 | 52 Week High | $39.41 | |||
| Open | $101.89 | 52 Week Low | $25.98 | |||
| Day High | $103.53 | P/E | 144.85 | |||
| Day Low | $101.25 | EPS | $0.71 | |||
| Volume | 581,580 | |||||
